We are live on ! Find out more
ACS

Archford Capital Strategies Portfolio holdings

AUM $987M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$136M
AUM Growth
+$10.2M
Cap. Flow
+$3.77M
Cap. Flow %
2.78%
Top 10 Hldgs %
30.52%
Holding
821
New
42
Increased
153
Reduced
89
Closed
40

Top Buys

Rank Stock Value
1
DOV icon
Dover
DOV
+$857K
2
AMT icon
American Tower
AMT
+$606K
3
D icon
Dominion Energy
D
+$401K
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$365K
5
XOM icon
ExxonMobil
XOM
+$332K

Top Sells

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$809K
2
GD icon
General Dynamics
GD
+$734K
3
MCD icon
McDonald's
MCD
+$700K
4
DGX icon
Quest Diagnostics
DGX
+$676K
5
TROW icon
T. Rowe Price
TROW
+$612K

Sector Composition

Rank Sector Weight
1 Industrials 16.97%
2 Technology 7.56%
3 Healthcare 5.69%
4 Consumer Staples 5.02%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
126
Medtronic
MDT
$116B
$129K 0.09%
1,791
+1,230
+219% +$85.4K
NGG icon
127
National Grid
NGG
$80.7B
$125K 0.09%
1,839
+510
+38% +$35.5K
BTU
128
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$125K 0.09%
1,080
– –
BAX icon
129
Baxter International
BAX
$14.3B
$118K 0.09%
2,964
-14,796
-83% -$576K
META icon
130
Meta Platforms (Facebook)
META
$1.53T
$118K 0.09%
1,508
– –
PEG icon
131
Public Service Enterprise Group
PEG
$37.5B
$118K 0.09%
2,845
+761
+37% +$30.6K
GSK icon
132
GSK
GSK
$102B
$117K 0.09%
2,191
-4,794
-69% -$268K
UAA icon
133
Under Armour
UAA
$2.29B
$112K 0.08%
3,300
– –
MBB icon
134
iShares MBS ETF
MBB
$39B
$110K 0.08%
1,005
-97
-9% -$10.6K
PPG icon
135
PPG Industries
PPG
$25.8B
$108K 0.08%
932
– –
AOK icon
136
iShares Core Conservative Allocation ETF
AOK
$791M
$98K 0.07%
2,993
-174
-5% -$5.67K
AVGO icon
137
Broadcom
AVGO
$1.98T
$98K 0.07%
9,790
-720
-7% -$6.43K
CPK icon
138
Chesapeake Utilities
CPK
$3.22B
$98K 0.07%
1,975
– –
PFE icon
139
Pfizer
PFE
$152B
$96K 0.07%
3,233
+76
+2% +$2.18K
BIDU icon
140
Baidu
BIDU
$35.9B
$94K 0.07%
411
– –
CELG
141
DELISTED
Celgene Corp
CELG
$94K 0.07%
844
+200
+31% +$21.1K
VNQ icon
142
Vanguard Real Estate ETF
VNQ
$38.3B
$93K 0.07%
1,153
– –
K
143
DELISTED
Kellanova
K
$92K 0.07%
1,491
– –
BA icon
144
Boeing
BA
$184B
$91K 0.07%
697
– –
XEL icon
145
Xcel Energy
XEL
$48.5B
$89K 0.07%
2,483
+544
+28% +$18.3K
KO icon
146
Coca-Cola
KO
$372B
$88K 0.06%
2,092
+1,482
+243% +$63.3K
BMY icon
147
Bristol-Myers Squibb
BMY
$130B
$82K 0.06%
1,391
– –
MRK icon
148
Merck
MRK
$322B
$81K 0.06%
1,488
– –
UNH icon
149
UnitedHealth
UNH
$361B
$81K 0.06%
800
– –
TGT icon
150
Target
TGT
$69.2B
$79K 0.06%
1,035
+837
+423% +$56.5K
4 5
6
7 8

Similar funds

PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
SMM
Stadion Money Management Watkinsville, Georgia $994M AUM 15.96% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SWA
Strategies Wealth Advisors Grand Rapids, Michigan $995M AUM 19.35% 1-Year Est. Return
GCM
Gladstone Capital Management London, United Kingdom $996M AUM 50.16% 1-Year Est. Return

Archford Capital Strategies's Q4 2014 Portfolio in Review

As of Q4 2014, Archford Capital Strategies held 821 positions worth $136M, up 8.1% from $126M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Archford Capital Strategies's Q4 2014 filing shows 42 new, 153 increased, 89 reduced and 40 closed positions. Its largest new stake was AstraZeneca: 3,994 shares worth $281K. The largest sale was CSX Corp, an estimated $809K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Archford Capital Strategies's largest Q4 2014 buy was AstraZeneca: 3,994 shares worth $281K.
  • Archford Capital Strategies added most to Dover in Q4 2014, an estimated $857K increase.
  • Archford Capital Strategies's biggest Q4 2014 reduction was CSX Corp, cutting an estimated $809K.
  • Archford Capital Strategies fully exited General Dynamics in Q4 2014, selling an estimated $734K.
  • Archford Capital Strategies's ten largest holdings make up 31% of its $136M portfolio in Q4 2014.
  • Archford Capital Strategies opened 42 new positions and closed 40 in Q4 2014.
  • Archford Capital Strategies's portfolio value rose 8.1% quarter-over-quarter to $136M.

Based on Archford Capital Strategies's 13F filing for Q4 2014, filed 3 Feb 2015.